Difficulty: Medium
Average Score: 85%
Practice
Which of the following cholinomimetics is a drug of choice for reversing the effects of nondepolarizing neuromuscular relaxants?
Correct answer
C
Rationale
The correct answer is C) Edrophonium. Edrophonium is a short-acting cholinesterase inhibitor that is commonly used to reverse the effects of nondepolarizing neuromuscular relaxants like rocuronium and vecuronium. It works by increasing the amount of acetylcholine available at the neuromuscular junction, thereby antagonizing the effects of the relaxant drugs.
A) Echothiophate is a long-acting cholinesterase inhibitor used in the treatment of glaucoma and not indicated for reversing neuromuscular relaxants.
B) Polypso-6-num is a fictitious drug name and not a recognized cholinomimetic agent.
D) Pilocarpine is a muscarinic agonist used to treat conditions like glaucoma and xerostomia, but it is not indicated for reversing neuromuscular blockade.
Understanding the appropriate pharmacological agents for reversing the effects of neuromuscular relaxants is crucial in clinical practice, especially in settings like anesthesia and critical care where these drugs are commonly used. Knowledge of drugs like edrophonium and their mechanisms of action can help healthcare professionals effectively manage patients who require reversal of neuromuscular blockade.
A) Echothiophate is a long-acting cholinesterase inhibitor used in the treatment of glaucoma and not indicated for reversing neuromuscular relaxants.
B) Polypso-6-num is a fictitious drug name and not a recognized cholinomimetic agent.
D) Pilocarpine is a muscarinic agonist used to treat conditions like glaucoma and xerostomia, but it is not indicated for reversing neuromuscular blockade.
Understanding the appropriate pharmacological agents for reversing the effects of neuromuscular relaxants is crucial in clinical practice, especially in settings like anesthesia and critical care where these drugs are commonly used. Knowledge of drugs like edrophonium and their mechanisms of action can help healthcare professionals effectively manage patients who require reversal of neuromuscular blockade.